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Summary 
The effect of liposomal entrapment on oral absorption of drugs was deter~ned from the excretion profiles of entrapped markers 
after oral administration to rats. Liposomal entrapment does not facilitate the uptake of PEG-4000, a non-absorbable, water-soluble 
marker. The excretion patterns of hydrocortisone and salicylic acid, when entrapped in L-a-phosphatidylcholine distearoyl/cholesterol 
or egg lecithin/cholesterol multilamellar or unilamellar liposomes, were not significantly different from the excretion patterns of the 
unencapsulated drugs. These results are in agreement with in vitro and in situ studies which suggest that liposomal entrapment does 
not influence the intestinal absorption of drugs and, moreover. does not even protect entrapped drugs from the environment of the 
gastrointestinal tract, The combined in vitro, in situ and in vivo results strongly indicate that liposomes show littk promise as a drug 
delivery system for oral ad~~stration. The increased oral b~oavailabi~ity of liposomally inco~orated drugs occasionally reported in 
the literature may be due to factors other than liposomal uptake. 
Introduction 
Attempts to use liposomes as an oral dosage 
form have been a major focus in drug delivery 
research in the past two decades. Since it has been 
suggested that liposomes may either protect the 
entrapped drugs from digestive degradation 
(Bangham et al., 1965) or increase the absorption 
of poorly absorbed drugs from the gastrointestinal 
tract (Sessa and Weissman, 1970), most of the 
studies in the literature are focussed on the effect 
of liposomal entrapment on oral absorption of 
drugs which are either poorly absorbed or drugs 
that are unstable in the gastrointestinal tract. For 
the most part, the results of these studies indicate 
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that liposomal entrapment either does not facili- 
tate oral absorption (Young et al., 1979; Kawada 
et al., 1981) or its influences on absorption are not 
predictable or reproducible (Arrieta-Molero et al., 
1982; Tragl et al., 1979). 
In a recent in vitro study on the stability of 
L-~-phosphatidylcholine distearoyl/chol~sterol 
and egg lecit~n/choIesterol muitil~ellar lipo- 
somes, we reported substantial loss of entrapped 
glucose and complete loss of entrapped carboxy- 
fluorescein under conditions similar to what would 
be expected in the gastrointestinal tract. Also, 
transport studies using in vitro diffusion cells and 
everted sac experiments suggested that liposomal 
entrapment does not facilitate the transport of 
non-absorbable drugs and prevents the transport 
of absorbable ones. In situ studies seemed to 
confirm this viewpoint since almost all of the 
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liposomes and their entrapped markers remain in 
the intestine even after 3 h (Chiang and Weiner, 
1987). 
On the other hand, there is a substantial body 
of literature which supports the views that lipo- 
somal entrapment offers protection for its en- 
capsulated drug in the environment of the gastro- 
intestinal tract (Rowland and Woodley, 1980) and 
facilitates the gastrointestinal transport of a variety 
of compounds (Nagata, et al., 1984; Dapergolas 
and Gregoriadis, 1976). Thus, despite two decades 
of research in this area, the utility of liposomes as 
an oral drug delivery system is still open to ques- 
tion. 
The present work is an investigation of the 
effect of liposomal entrapment on in vivo absorp- 
tion in the rat. In particular, we have sought 
insight into the following questions: 
1. Do liposomes maintain their integrity in the 
physiological environment of the gastrointesti- 
nal tract? 
2. Are non-absorbable markers (e.g., PEG-4000), 
when encapsulated into liposomes, able to 
traverse the gastrointestinal tract? 
3. Does encapsulation into liposomes affect the 
gastrointestinal uptake of absorbable markers 
(e.g., salicylic acid and hydrocortisone)? 
Materials and Methods 
Materials 
The lipids used were L-a-phosphatidylcholine 
distearoyl (Sigma Chemicals Co., St. Louis, MO), 
egg phosphatidylcholine (Avanti Polar Lipids, Bir- 
mingham, AL) and cholesterol (Sigma). L-a-Phos- 
phatidylcholine distearoyl and egg lecithin were 
used as purchased and stored below 0” C. 
Cholesterol was recrystallized from ethanol solu- 
tion 3 times. All liposome preparations that em- 
ployed cholesterol were prepared using a phos- 
pholipid: cholesterol molar ratio of 2 : 1. The ra- 
diolabelled compounds that were used as en- 
trapped markers, [14C]PEG-4000, [i4C]salicylic 
acid and [ 3H]hydrocortisone were purchased from 
New England Nuclear (Boston, MS). All radio- 
labelled markers were diluted with their unlabeled 
counterparts. All other chemicals were of reagent 
grade and used as obtained. 
Preparation of liposomes 
L-a-Phosphatidylcholine distearoyl/cholesterol 
and egg lecithin/cholesterol multilamellar vesicles 
were prepared by the method described by Chiang 
and Weiner (1987). Briefly, the lipid mixtures (32 
pmol phospholipid and 16 pmol cholesterol) were 
dried from a chloroform solution at room temper- 
ature in a 20 ml glass scintillation vial (Kimble, 
Toledo, OH). Hydrocortisone which was to be 
entrapped was dissolved together with the phos- 
pholipids in the organic solvent while PEG-4000 
and salicylate were dissolved in the aqueous buffer. 
A thin film was formed on the sides of the vial by 
hand agitation during the drying process and re- 
sidual solvent was removed by storing the vial 
overnight under vacuum. The dried lipids were 
then hydrated with 1.0 ml of 67 mM phosphate 
buffer solution (pH 7.0) at a temperature above 
the transition temperature of the constituent phos- 
pholipid (61°C for liposomes composed of L-CY- 
phosphatidylcholine distearoyl/cholesterol and 
room temperature for liposomes composed of egg 
lecithin/cholesterol). Incubation of the lipid film 
with buffer was carried out for 30 min with inter- 
mittent vortexing. The suspension was then soni- 
cated in a bath-type sonicator (Branson Cleaning 
Equipment Co., Shelton, CN) for 30 s at the same 
temperature at which the films were hydrated, and 
the resultant dispersion was allowed to equilibrate 
for at least 4 h at room temperature. The disper- 
sion was passed through a 2.0-pm polycarbonate 
filter (Nucleopore Corp., Pleasanton, CA) so as to 
remove large aggregates. The suspension was then 
centrifuged 3 times at 10,000 rpm for 5 min to 
remove untrapped marker from the liposome pre- 
parations. After each centrifugation step, the su- 
pernatant was removed and the liposomes pellet 
was resuspended in 2 ml of fresh buffer. After the 
final centrifugation step, the supernatant was as- 
sayed to ensure complete removal of free marker. 
L-a-Phosphatidylcholine distearoyl/cholesterol 
large unilamellar vesicles were prepared by the 
reverse-phase evaporation technique described by 
Szoka and Papahadjopoulos (1978). Briefly, the 
lipid mixture (48 pmol phospholipid and 24 pmol 
cholesterol) was placed in a 50-ml round-bottom 
flask and the mixture was then dissolved in an 
organic solvent containing 6 ml each of chloro- 
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form and isopropyl ether. Hydrocortisone which 
was to be entrapped was dissolved together with 
the phospho~pids in the organic solvent while 
PEG-4000 was dissolved in the aqueous buffer. 
Two ml of buffer were added, and the resulting 
two-phase system was purged with N, and soni- 
cated briefly (2-5 min) until the mixture became a 
well-mixed opalescent dispersion. The temperature 
of sonication was m~nt~ned at 61° C (4” C above 
the transition temperature of distearoylphos- 
phatidylcholine). Finally, the dispersion was placed 
in a rotary evaporator and the organic solvent was 
removed under reduced pressure at 61’C. As the 
solvent evaporated, the mixture first formed a 
viscous gel followed by a loss in viscosity to yield 
a fluid dispersion. At this point, excess buffer (1.5 
ml) was added and the solvents were allowed to 
evaporate for an additional 10 min on the rotary 
evaporator to facilitate removal of trace amounts 
of organic solvent. The dispersion was then re- 
moved from the rotary evaporator and was main- 
tained for 30 min in a 61°C water bath. The 
suspension was then centrifuged 3 times at 10,000 
rpm for 5 min to remove untrapped marker. After 
each centrifugation step, the supernatant was re- 
moved and the liposomal pellet was resuspended 
in 4 ml of fresh buffer. After the final centrifuga- 
tion step, the supernatant was assayed to ensure 
complete removal of free marker. 
Determination of excretion profiles of free and lipo- 
sorn~l~y entrapped PE~-4~0~ and ~ydro~ort~sone 
Male Sprague-Dawley rats weighing 325-375 g 
were fasted overnight after being kept in meta- 
bolic cages (Nalge Co., Rochester, NY) for 4 days 
prior to initiation of the experiment. A no. 16 
biomedical needle f - 7 cm long) was fitted to a 
5-ml syringe and the test preparations were drawn 
up through the needle into the syringe. The needle 
was then inserted into the rat’s mouth and through 
its esophagus and one to two ml of the following 
preparations were administered through the 
needle: 
1. Aqueous solutions of PEG-~0 ( = 1 mg) or 
hydrocortisone (= 0.1 mg); 
2. PEG-4000 (= 1 mg) or hydrocortisone (a 0.1 
mg) entrapped in: 
a. L-cu-phosphatidylcholine distearoyl/ cho- 
lesterol multilamellar liposomes; 
b. egg lecithin/cholesterol multilamellar 
liposomes; 
c. L-ff-phosphatidylcho~ne distearoyl/ cho- 
lesterol large unilamellar vesicles. 
The fasting period was ended 4 h after adminis- 
tration of the test preparations. Water was given 
ad hbitum throughout the experimental period 
and urine samples were collected at various time 
intervals for 48 h and assayed for radioacti~ty. 
Determination of excretion profiles of free and lipo- 
somally entrapped salicylic acid 
Femoral vein cannulation (to induce urine out- 
put) and bladder cannulation (to facilitate collec- 
tion of urine) were used for this phase of the study 
since the rapid pharmacokinetics of salicylic acid 
necessitated frequent collection of urine samples. 
Male Sprague-Dawley rats, weight 330-370 g, 
were anesthetized by injection with sodium 
pentobarbital (50 mg/kg) i.p. Following the in- 
duction of anesthesia, the rats were fastened to an 
operating table which was covered with a tempera- 
ture-controlled heating pad. 20% ethyl carbamate 
was administered as needed during the experimen- 
tal period to maintain an anesthetized state. 
The catheter used for femoral vein cannulation 
was prepared by fitting a 25-cm section of PE-50 
tubing (Clay Adams, Parsippany, NJ) onto a 23- 
gauge needle attached to a l-ml disposable syringe. 
The other end of the tubing was beveled to facili- 
tate insertion into the femoral vein and the system 
was flushed with sodium heparin solution fol- 
lowed by normal saline. Following removal of the 
syringe the needle, connected to the polyethylene 
tubing, was attached to a three-way stopcock which 
was, in turn, placed directly on the hub of a 20-ml 
syringe cont~~ng the infusion solution. 
A small groin incision was made with scissors 
and the femoral vein was exposed by rending the 
fat with the aid of forceps. The vein was then 
carefully separated from the remaining fascia using 
blunted forceps and two ligatures were placed 
under the femoral vein. The ligature closest to the 
distal end of the vein was pulled, tied tightly and 
taped firmly to the surgical table to keep the 
vessel taut. The second ligature was positioned at 
the proximal end of the vessel. After a small cut 
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was made in the vein between the two ligatures, 
and the catheter was introduced into this opening 
and eased into the vein, the second ligature was 
tied firmly around the vessel and the catheter. The 
area was then covered with gauze and kept moist 
with normal saline. 
For the bladder cannulation, a midline incision 
was made in the abdomen of the rat to expose the 
bladder and urine was drained from the bladder 
using a l-ml syringe with a 23-gauge needle at- 
tached. A purse-string suture was then made ap- 
proximately 0.5 cm from the apex of the bladder 
using a l/2 circle point needle (The Torrington 
Co., Torrington, CN). A small cut was made in 
the center of the suture area and a 10 cm section 
of PE-90 tubing, flanged at one end to prevent the 
cannula from slipping out of the bladder, was 
inserted. The suture was then pulled tightly and 
tied and the bladder was covered with gauze and 
kept moist with normal saline. 
Following the surgical procedures described 
above, 0.9% saline containing 4% manmtol in a 
20-ml syringe was infused via the femoral vein 
with a Harvard Apparatus infusion pump (Har- 
vard Apparatus, Millis, MS). The infusion rate 
was 0.2 ml/mm for the first 10 mm and then 
adjusted to 0.1 ml/mm throughout the remainder 
of the experiment. These rates were found to 
facilitate reasonable urine outputs (ca. 3-4 ml/h). 
The following preparations were then adminis- 
tered in the manner described in the previous 
section: 
1. Aqueous solution of salicylic acid (= 0.1 mg); 
2. Salicylic acid (= 0.1 mg) entrapped in ~-a- 
phosphatidylcholine distearoyl/cholesterol 
multilamellar liposomes. 
Urine samples were then collected every 30 min 
for 4 h and were assayed by scintillation counting. 
Results and Discussion 
Upon oral administration of either free or lipo- 
somally entrapped PEG-4000, a water-soluble, 
non-absorbable marker, no radioactivity was de- 
tected in the urine, even after 48 h. The inability 
of liposomal encapsulation to facilitate uptake of 
this marker is in agreement with in vitro intestinal 
everted sac experiments (Whitmore and Wheeler, 
1979; Seiden and Lichtenberg, 1979) and in situ 
studies using the Doluisio technique (Schwinke et 
al., 1984). On the other hand, in vitro experiments 
using everted sacs (Rowland and Woodley, 1981; 
Kimura et al., 1984) and isolated perfused intesti- 
nal loop systems (Pate1 et al., 1985). have led a 
number of investigators to suggest that liposomal 
entrapment of macromolecules may facilitate their 
intestinal absorption by an endocytosis mecha- 
nism. Chiang and Weiner (1987) point out that the 
evidence does not support endocytosis as a signifi- 
cant absorptive pathway, even if the liposomes 
retained their entrapped markers in the gastroin- 
testinal tract. 
Hydrocortisone and salicylic acid were chosen 
as markers because they represent drugs that are 
well absorbed and whose pharmacokinetics are 
defined in the rat (Wyngaarden et al., 1955; Yue 
and Varma, 1982). Furthermore, they are available 
as radiolabelled compounds and their intestinal 
uptake can be monitored by determining the 
cumulative percentage of radioactivity excreted in 
the urine as a function of time (Kirkpatrick et al., 
1983; Yue and Varma, 1982). 
The excretion profiles for free and liposomally 
entrapped hydrocortisone are shown in Fig. 1. 
Approximately 15% of the radioactivity (free hy- 
drocortisone and metabolites) was recovered in 
the urine within two days after oral administration 
of free or liposomally entrapped hydrocortisone. 
Most of the radioactivity appeared within the first 
24 h. The low percentage of recovery in urine is in 
agreement with data reported by Wyngaarden et 
al. (1955) who showed that after subcutaneous 
administration of radiolabelled drug to normal 
rats, most of the hydrocortisone and its metabo- 
lites appear in the feces as a result of transport to 
the gut via bile. 
The liposomal type used (multilamellar or large 
unilamellar vesicles) and the constituent lipid 
composition (distearolphosphatidylcholine or egg 
lecithin) did not affect the excretion pattern. More 
importantly, liposomal encapsulation has no effect 
on the extent and rate of hydrocortisone absorp- 
tion after oral administration as determined by 
one-way ANOVA (P > 0.05). 
Since these results suggest that the various lipo- 
0 Free 
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Fig. 1. Cumulative percentage of radioactivity excreted in urine after oral administration to rats of aqueous solutions of 
hydrocortisone or hydrocortisone entrapped in t,-a-phosphatidylcholine distearoyl/cholesterol (DSPC/CH) multilamellar liposomes 
(MLV), egg lecithin/cholesterol (EL/CH) multilamellar liposomes or -cr-phosphatidylcholine distearoyl/cholesterol large unilamellar 
vesicles (LUV). Bar denotes S.E.M. See text for experimental details. 
somal preparations used were not stable in the 
gastrointestinal tract resulting in rapid leakage 
and subsequent absorption of free hydrocortisone, 
the salicylic acid studies were carried out by incor- 
porating the marker into liposomes reported to be 
most stable in the environment of the gastroin- 
testinal tract (Rowland and Woodley, 1980), i.e., 
r_-a-phosphatidylcholine distearoyl/cholesterol 
multilamellar liposomes. The excretion profiles for 
free and liposomally entrapped salicylic acid using 
cannulated rats are shown in Fig. 2. Again, lipo- 
somal encapsulation has no effect on the extent 
and rate of salicylic acid absorption after oral 
administration as determined by the Student’s t- 
test (P > 0.05). 
Based on the similarity of the excretion profiles 
of unentrapped and entrapped hydrocortisone and 
salicyclic acid, it appears that the primary reason 
that liposomal encapsulation does not influence 
oral absorption is a result of the liposome’s inabil- 
ity to retain entrapped marker in the gastrointesti- 
nal system. This view is supported by in vitro 
(Chiang and Weiner, 1987) and in vivo (Wu, et al., 
1982; Mauk and Gamble, 1979; Hwang, 1983) 
studies which demonstrate the high degree of 
leakiness of diverse markers from liposomes in the 
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Fig. 2. Cumulative percentage of radioactivity excreted in urine 
after oral administration to cannulated rats of aqueous solu- 
tions of salicylate or salicylate entrapped in L-cy-phosphati- 
dylcholine distearoyl/cholesterol multilamellar liposomes. Bar 
denotes S.E.M. See text for experimental details. 
gastrointestinal tract. Studies which report at- 
tempts to increase the gastrointestinal absorption 
of water-soluble drugs (Ueno et al., 1982), water- 
insoluble drugs (Nagata et al., 1984) ionophores 
(Young et al., 1979) and a variety of polypeptides 
and proteins (Hemker et al., 1980) further support 
the view that liposomal entrapment either does 
not facilitate oral absorption (Young et al., 1979) 
or affects absorption somewhat, but in a non- 
predictable manner (Jaskierowicz et al., 1985). 
The large body of literature concerning the oral 
absorption of liposomally entrapped insulin is rep- 
resentative of the conflicting views on the ability 
of liposomal encapsulation to facilitate oral ab- 
sorption. The emphasis on this drug can be attri- 
buted to the suggestion that liposomes can protect 
insulin from degradation in the gastrointestinal 
tract and thus reduce the blood glucose levels. For 
the most part, the data suggest that liposomally 
entrapped insulin does not lower blood glucose 
levels in normal subjects (Pate1 and Ryman, 1977; 
Kawade et al., 1981; Pate1 et al., 1982) and only 
about 1% of the administered dose of liposomally 
entrapped insulin appeared in the plasma within 
60 min in normal human subjects (Pate1 et al., 
1978). However, Dapergolas and Gregoriadis 
(1976) suggested that oral administration of lipo- 
somally entrapped insulin to normal rats pro- 
duced a significant drop in blood glucose. Al- 
though hypoglycemia was observed after adminis- 
tering liposomally entrapped insulin to diabetic 
rats (Pate1 and Ryman, 1976; Hashimoto and 
Kawada, 1979) the reduction in blood glucose 
reported in the literature was neither dose-depen- 
dent nor easily reproduced (Arrieta-Molero et al., 
1982; Tragl et al., 1979). 
A number of related studies may help explain 
why a hypoglycemic effect is at times observed 
upon oral administration of liposomally entrapped 
insulin. Weingarten et al. (1985) found that insulin 
in solution was protected from enzymatic de- 
gradation upon incubation with empty liposomes, 
indicating that simple adsorption of insulin to the 
external phospholipid bilayer may protect it from 
proteolytic enzymes. Furthermore, Shichir et al. 
(1976) showed that various types of emulsions can 
assist the intestinal uptake of insulin. Thus, the 
hypoglycemia observed need not be dependent on 
the uptake of intact liposomes or even on insulin 
remaining entrapped in liposomes but may be the 
result of an interaction between insulin, lipids and 
bile salts. 
There are other examples where liposomal en- 
trapment of a drug appears to facilitate oral ab- 
sorption. For example, Nagata et al. (1984) in 
their study of vitamin K absorption, reported that 
coagulation recovery following oral administration 
of liposomally entrapped vitamin K was faster 
than that for other preparations of the vitamin. 
The enhancement of vitamin K absorption can 
again be explained without resorting to a mecha- 
nism based on retention of drug in the liposome 
or gastrointestinal uptake of liposomes. Since the 
absorption of oil-soluble vitamins requires the 
presence of bile salts in the intestine, liposomal 
entrapment may simply increase access of the 
vitamin to the bile salt micelles and their subse- 
quent micellar solubilization, thus facilitating the 
uptake of the vitamin. 
The combined results of our in vitro and in 
vivo experiments demonstrate that liposomes do 
not influence the oral absorption of their en- 
trapped drug. Furthermore, even the most “stable” 
liposomes do not retain entrapped marker in the 
gastrointestinal tract and hence will not even pro- 
tect the drug from its hostile environment. The 
increased oral bioavailability of liposomally incor- 
porated drugs occasionally reported in 
ture may be due to factors other than 
uptake. Therefore, liposomes appear to 
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